Copegus, a new ribavirin tablet for hepatitis C

January 2003

You'll soon see prescriptions for Copegus, a new ribavirin tablet for hepatitis C.

Copegus is an antiviral approved for use in combination with Pegasys (peginterferon alfa-2a).

Copegus is equivalent to Rebetol...but dosing is slightly different.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

landmark NIH hypertension study will change how patients with high blood pressure are treated
Strattera, the first NON-stimulant drug approved for ADHD
Provigil (modafinil), the latest prescription "lifestyle drug"
some patients are accidentally overdosing on their methotrexate
Cardiology You'll be hearing a lot about C-reactive protein
Cardiology statins decrease the effects of Plavix
Dermatology treatments for wrinkles
Dermatology Aldara (imiquimod cream) to treat actinic keratoses
Infectious Diseases Copegus, a new ribavirin tablet for hepatitis C
Infectious Diseases how to treat gonorrhea now that Wyeth is discontinuing cefixime (Suprax)
Women's Health how to treat women with epilepsy
Natural Medicines "seals of approval" on brand name dietary supplements
Osteoporosis Forteo (teriparatide), human parathyroid hormone for treating osteoporosis
Is it legal for patients to import prescription drugs
whether a "float test" tells if a metered-dose inhaler is empty